GINKGO BIOWORKS HOLDINGS, INC. (DNA) Current Ratio
- Current ratio · latest quarter: Value 4.57×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.57× | Current assets / current liabilities. $332.54M ÷ $72.74M ≈ 4.57× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 332.54M USD | Assets, Current |
| Current obligations | 72.74M USD | Liabilities, Current |
| Cash and equivalents | 84.53M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 13.01M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 9.57M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $332.54M | $72.74M | $84.53M | (m) | $13.01M | (m) | $9.57M | (m) | 4.57× |
| 2026-03-31 | $409.95M | $79.59M | $143.86M | (m) | $19.82M | (m) | $16.31M | (m) | 5.15× |
| 2025-12-31 | $471.84M | $95.97M | $167.20M | (m) | $24.03M | (m) | $10.57M | (m) | 4.92× |
| 2025-09-30 | $506.08M | $115.28M | $111.06M | $384.42M | $21.43M | (m) | $10.70M | (m) | 4.39× |
| 2025-06-30 | $523.02M | $96.72M | $203.57M | $355.79M | $22.15M | (m) | $11.20M | (m) | 5.41× |
| 2025-03-31 | $564.53M | $115.67M | $312.42M | $12.84M | $26.29M | (m) | $11.27M | (m) | 4.88× |
| 2024-12-31 | $602.74M | $107.27M | $561.57M | $0.00 | $21.86M | (m) | $14.17M | (m) | 5.62× |
| 2024-09-30 | $662.48M | $114.43M | $616.21M | (m) | $23.41M | (m) | $15.70M | (m) | 5.79× |
| 2024-06-30 | $783.36M | $166.15M | $730.37M | (m) | $18.59M | (m) | $23.03M | (m) | 4.71× |
| 2024-03-31 | $903.02M | $169.04M | $840.44M | (m) | $24.19M | (m) | $27.00M | (m) | 5.34× |
| 2023-12-31 | $1.00B | $163.86M | $944.07M | (m) | $17.16M | (m) | $9.32M | (m) | 6.11× |
| 2023-09-30 | $1.14B | $168.46M | $1.05B | (m) | $61.90M | $70.00K | $10.75M | (m) | 6.78× |
| 2023-06-30 | $1.22B | $163.33M | $1.11B | (m) | $68.02M | $391.00K | $13.63M | (m) | 7.49× |
| 2023-03-31 | $1.33B | $191.70M | $1.21B | (m) | $83.26M | $2.51M | $21.57M | (m) | 6.92× |
| 2022-12-31 | $1.45B | $172.96M | $1.32B | (m) | $80.91M | $4.36M | $10.45M | (m) | 8.38× |
| 2022-09-30 | $1.46B | $124.82M | $1.30B | (m) | $113.66M | $5.86M | $11.32M | (m) | 11.71× |
| 2022-06-30 | $1.60B | $135.02M | $1.38B | (m) | $171.62M | $8.10M | $19.46M | (m) | 11.84× |
| 2022-03-31 | $1.71B | $159.25M | $1.49B | (m) | $167.26M | $8.70M | $35.26M | (m) | 10.71× |
| 2021-12-31 | $1.72B | $134.76M | $1.55B | (m) | $131.54M | $3.36M | $8.19M | (m) | 12.79× |
| 2021-09-30 | $1.81B | $90.31M | $1.74B | (m) | $44.67M | $3.47M | $7.10M | (m) | 20.05× |
| 2021-06-30 | $966.88K | $4.69M | $37.63K | (m) | (m) | (m) | (m) | (m) | 0.21× |
| 2021-03-31 | $2.99M | $1.42M | $1.92M | (m) | (m) | (m) | (m) | (m) | 2.10× |
| 2020-12-31 | $426.54M | $73.22M | $380.80M | (m) | $16.69M | $2.74M | $13.89M | (m) | 5.83× |
| 2019-12-31 | $511.93M | $40.07M | $495.29M | (m) | $3.46M | $0.00 | $2.44M | (m) | 12.77× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.